Etodolac NDC 63187-736

Product information

Brand name (proprietary)

Etodolac

Generic name (nonproprietary)

etodolac

Active ingredients

Etodolac — 400 mg/1

Dosage form

Tablet, Film coated

Route

Oral

Labeler

Proficient Rx LP

Product type

Prescription drug

Marketing category

ANDA — Abbreviated New Drug Application (generic)Application ANDA 076004

Marketing start

May 1, 2003

Listing expires

Dec 31, 2026

Other FDA classes

Non-Steroidal (Chemical structure)Cyclooxygenase Inhibitors (Mechanism)

Identifiers

Product ID 63187-736_1df6a536-d2d9-4d3b-bc5b-91e7a26beed2SPL ID 1df6a536-d2d9-4d3b-bc5b-91e7a26beed2SPL set ID e2fef939-2f4a-46ae-8177-073f5e8f57f5RxCUI 197686UNII 2M36281008UPC 0363187736200

Pharmacologic class

Nonsteroidal Anti-inflammatory Drug

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N463187073620 followed by a unit qualifier and the quantity Copy

Package 63187-0736-20. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Other NDCs under ANDA 076004

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.